New research suggests that green tea may have a role to play in the development of drugs to treat tumours and a hereditary disease.
The research, published in The Journal of Biological Chemistry, focuses on glutamate dehydrogenase (GDH), a substance used to digest the amino acids found in proteins. When the human body fails to regulate GDH the consequences can be fatal, causing the disease hyperinsulinism/hyperammonemia (HHS).
Researchers isolated two compounds in green tea which turn off the GDH system, and believe these compounds could form the basis for new drugs to address HSS.
The compound’s ability to manipulate GDH also makes it a potentially effective treatment for glioblastomas, a brain tumour, and tuberous sclerosis complex disorder, an inherited disease that causes non-malignant tumours.
Source: Ingredients Network
